Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG)-Reference-Cited by-同舟云学术

Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG)

Published:2004-05-11 Issue:12 Volume:90 Page:2305-2311
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Classen J,Schmidberger H,Meisner C,Winkler C,Dunst J,Souchon R,Weissbach L,Budach V,Alberti W,Bamberg M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6601867.pdf

Reference32 articles.

1. Bamberg M, Schmidberger H, Meisner C, Classen J, Souchon R, Weinknecht S, Schorcht J, Walter F, Engenhart-Cabillic R, Schulz U, Born H, Flink M (1999) Radiotherapy for stage I, IIA/B testicular seminoma. Int J Cancer 83: 823–827

2. Bauman GS, Venkatesan VM, Ago CT, Radwan JS, Dar AR, Winquist EW (1998) Postoperative radiotherapy for Stage I/II seminoma: results for 212 patients. Int J Radiat Oncol Biol Phys 42: 313–317

3. Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878–1886

4. Busch FM, Sayegh ES, Chenault OW (1965) Some uses of lymphangiography in the management of testicular tumors. J Urol 93: 490–495

5. Classen J, Souchon R, Hehr T, Bamberg M (2001) Treatment of early stage testicular seminoma. J Cancer Res Clin Oncol 127: 475–481

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Control, Toxicity, and Secondary Malignancy Risks of Proton Radiation Therapy for Stage I-IIB Testicular Seminoma;Advances in Radiation Oncology;2023-09

2. Therapie des Seminoms im klin. Stadium I und IIA/B;Die Urologie;2023

3. Therapie des Seminoms im klin. Stadium I und IIA/B;Die Urologie;2022

4. Testicular Cancer Radiotherapy;Practical Guides in Radiation Oncology;2021

5. Seminom CS I: adjuvante Therapie;Uroonkologie;2019